Multimodal Intervention Program for Patients With Metabolic Syndrome (PROMETS)

June 20, 2017 updated by: Jaqueline Garcia da Silva, Universidad de Granada

Development and Validation of a Multimodal Intervention Program for Patients With Metabolic Syndrome

The aim of this study is to identify the psychological, emotional and lifestyle variables that can have an influence on the different components of metabolic syndrome (MetS) and develop a program for change lifestyle in this patients.

Study Overview

Study Type

Interventional

Enrollment (Actual)

136

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Granada, Spain, 18009
        • Jaqueline Garcia da Silva

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Between 25 and 65 years age
  • Waist circumference >88 cm for women and >102 cm for men
  • Blood pressure: systolic ≥ 130 mmHg and diastolic ≥ 85 mmHg
  • Fasting glucose level ≥ 110mg/dL
  • Triglycerides: ≥ 150 mg/dL
  • HDL cholesterol ≤40 mg/dL in men and ≤50 mg/DL in women

Exclusion Criteria:

  • Osteoarthritis,
  • Active inflammatory diseases,
  • Severe psychiatric disorders and/or significant cognitive impairment assessed using the Mini-Mental State Examination.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Multimodal intervention program
The intervention program will be in group format, with a size of 10 to 12 patients per group and with an extension of 12 sessions. The treatment program will feature sessions with psychoeducation of metabolic syndrome and treatment model, problem solving, stress management, anger management, social skills, self-efficacy and social support.

The intervention is structured as follows:

Review of previous session (20 min) Agenda and goals (5 min) Presentation of the topic to be worked (15 min) Training (60 min) Summary and feedback (15 min)

Active Comparator: Lifestyle counseling
The group of lifestyle counseling will have basic guidelines, according to the recommendations of public health.
The group of lifestyle counseling will have basic guidelines, according to the recommendations of public health.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight
Time Frame: 2 minutes
weight (Kg)
2 minutes
Waist circumference
Time Frame: 2 minutes
(cm). Measured using a tape measure placed in a horizontal plane, located at the midpoint between the last rib and the iliac crest
2 minutes
Blood pressure
Time Frame: 15 minutes
Taken according to the recommendations of the American Heart Association, and considering the mean of three readings, each separated by two minutes.
15 minutes
Lipid profile
Time Frame: 3 minutes
lipid profile (HDL-C, total cholesterol, triglycerides)
3 minutes
Glycemic profile (fasting glucose)
Time Frame: 3 minutes
glycemic profile (fasting glucose)
3 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
State-Trait Anger Expression Inventory-2 - STAXI-2
Time Frame: 5 minutes
To determine diverse components of anger, such as experience, expression and control, as well as its facets such as state and trait, the Inventory of Expression of Anger State-Trait (STAXI-2) was used. It consists of 49 items organised in 6 scales and 5 subscales, permitting the attainment of an index for each scale and subscale, as well as a general index of the inventory.
5 minutes
Perceived Stress Scale -PSS
Time Frame: 5 minutes
To measure the perceived stress during the previous month, the Perceived Stress Scale was used, with a total of 14 items.
5 minutes
Assertiveness Inventory
Time Frame: 5 minutes
To evaluate the general assertiveness, the Assertiveness Inventory (AI) consisting of 30 items was used .
5 minutes
Medical Outcomes Study 12-Item Short Form - SF-12
Time Frame: 5 minutes
To determine the health-related quality of life the Medical Outcomes Study 12-Item Short Form (SF-12), which is composed of two components related to physical and mental health, was used.
5 minutes
Mediterranean-diet scale
Time Frame: 5 minutes
To evaluate the level of adherence to the Mediterranean diet (MedDiet). Consisting of 14 items that evaluate whether foods are included that can prevent cardiovascular risk such as olive oil, fish, vegetables, fruits, cereals and also foods that can increase the chances of risk such as cold meats, trans fats and excess salt. The degree of adherence to the MedDiet is given by the sum of the items. A score below 11 is considered low adherence and higher than 11 as high.
5 minutes
Fagerström Test for Nicotine Dependence
Time Frame: 5 minutes
To evaluate the degree of physical dependence on nicotine. The test consists of six items with two or four response alternatives. The score ranges from 0 to 10. High scores in the FTND (6 or more) indicate a high degree of dependence.
5 minutes

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mini Mental State Examination - MMSE
Time Frame: 5 minutes
To assess the initial mental state of the patient and possible cognitive deficits.
5 minutes
Mini International Neuropsychiatric Interview - MINI
Time Frame: 30 minutes
Brief diagnostic interview, compatible with the DSM-V and ICD-10 criteria was used to evaluate possible co-morbidities in the sample.
30 minutes
Height
Time Frame: 2 minutes
height (cm)
2 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2013

Primary Completion (Actual)

September 1, 2016

Study Completion (Actual)

October 1, 2016

Study Registration Dates

First Submitted

October 14, 2016

First Submitted That Met QC Criteria

October 27, 2016

First Posted (Estimate)

October 31, 2016

Study Record Updates

Last Update Posted (Actual)

June 21, 2017

Last Update Submitted That Met QC Criteria

June 20, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Syndrome X

Clinical Trials on Multimodal intervention program

Subscribe